← Back

Medicine

Topic spotlight
TopicWorld Wide

medicine

Discover seminars, jobs, and research tagged with medicine across World Wide.
70 curated items60 Seminars7 Positions3 ePosters
Updated in 3 months
70 items · medicine
70 results
SeminarNeuroscience

Decoding stress vulnerability

Stamatina Tzanoulinou
University of Lausanne, Faculty of Biology and Medicine, Department of Biomedical Sciences
Feb 19, 2026

Although stress can be considered as an ongoing process that helps an organism to cope with present and future challenges, when it is too intense or uncontrollable, it can lead to adverse consequences for physical and mental health. Social stress specifically, is a highly prevalent traumatic experience, present in multiple contexts, such as war, bullying and interpersonal violence, and it has been linked with increased risk for major depression and anxiety disorders. Nevertheless, not all individuals exposed to strong stressful events develop psychopathology, with the mechanisms of resilience and vulnerability being still under investigation. During this talk, I will identify key gaps in our knowledge about stress vulnerability and I will present our recent data from our contextual fear learning protocol based on social defeat stress in mice.

PositionArtificial Intelligence

Dr. Robert Legenstein

Graz University of Technology
Austria
Dec 5, 2025

For the recently established Cluster of Excellence CoE Bilateral Artificial Intelligence (BILAI), funded by the Austrian Science Fund (FWF), we are looking for more than 50 PhD students and 10 Post-Doc researchers (m/f/d) to join our team at one of the six leading research institutions across Austria. In BILAI, major Austrian players in Artificial Intelligence (AI) are teaming up to work towards Broad AI. As opposed to Narrow AI, which is characterized by task-specific skills, Broad AI seeks to address a wide array of problems, rather than being limited to a single task or domain. To develop its foundations, BILAI employs a Bilateral AI approach, effectively combining sub-symbolic AI (neural networks and machine learning) with symbolic AI (logic, knowledge representation, and reasoning) in various ways. Harnessing the full potential of both symbolic and sub-symbolic approaches can open new avenues for AI, enhancing its ability to solve novel problems, adapt to diverse environments, improve reasoning skills, and increase efficiency in computation and data use. These key features enable a broad range of applications for Broad AI, from drug development and medicine to planning and scheduling, autonomous traffic management, and recommendation systems. Prioritizing fairness, transparency, and explainability, the development of Broad AI is crucial for addressing ethical concerns and ensuring a positive impact on society. The research team is committed to cross-disciplinary work in order to provide theory and models for future AI and deployment to applications.

Position

Felipe Tobar

Universidad de Chile
Universidad de Chile
Dec 5, 2025

The Initiative for Data & Artificial Intelligence at Universidad de Chile is looking for Postdoctoral Researchers to join a collaborative team of PIs working on theoretical and applied aspects of Data Science. The role of the postholder(s) is twofold: first, they will engage and collaborate in current projects at the Initiative related to statistical machine learning, natural language processing and deep learning, with applications to time series analysis, health informatics, and astroinformatics. Second, they are expected to bring novel research lines affine to those currently featured at the Initiative, possibly in the form of theoretical work or applications to real-world problems of general interest. These positions are offered on a fixed term basis for up to one year with a possibility for a further year extension.

Position

Bharath Ramesh

International Centre for Neuromorphic Systems, Western Sydney University
Western Sydney University
Dec 5, 2025

The International Centre for Neuromorphic Systems, Western Sydney University, invites both domestic and international students to apply for the world’s first Master of Neuromorphic Engineering courses. We offer several programs, including a Graduate Certificate, a Graduate Diploma, a 1.5-year industry-oriented degree and a two-year research-oriented Master’s course in Neuromorphic Engineering. We seek dedicated, curious and open-minded scientists, engineers, physicists, electronics tinkerers, hardware and software hackers, and roboticists from diverse backgrounds. The course builds on the research background of our Neuromorphic Engineering and Event-Based Processing research staff. Successful applicants will receive significant mentorship. Mentors and course instructors will equip students with special digital vision and audition processing capabilities which are rarely taught at other Universities in the world. Mentors and instructors will provide students with opportunities to apply skills learned to practical projects which align with industry need. Although the post graduate courses will equip graduates with many in-demand machine-learning techniques, Neuromorphic Engineering researchers go beyond status-quo Machine Learning so that they can find solutions to issues that block progress in AI machine learning sensing and computer vision. Neuromorphic Engineering seeks to progress beyond failures in regular machine learning approaches as conventional approaches usually fail to generalise, are not environmentally sustainable, and are poorly suited to high-stakes time-critical low-powered applications.

Position

Maxime Carrière

Freie Universität Berlin
Berlin, Germany
Dec 5, 2025

The ERC Advanced Grant “Material Constraints Enabling Human Cognition (MatCo)” at the Freie Universität Berlin aims to build network models of the human brain that mimic neurocognitive processes involved in language, communication and cognition. A main strategy is to use neural network models constrained by neuroanatomical and neurophysiological features of the human brain in order to explain aspects of human cognition. To this end, neural network simulations are performed and evaluated in neurophysiological and neurometabolic experiments. This neurocomputational and experimental research targets novel explanations of human language and cognition on the basis of neurobiological principles. In the MatCo project, 3 positions are currently available: 1 full time position for a Scientific Researcher at the postdoctoral level Fixed-term (until 30.9.2025), Salary Scale 13 TV-L FU ID: WiMi_MatCo100_08-2022, 2 part time positions (65%) for Scientific Researchers at the predoctoral level Fixed-term (until 30.9.2025), Salary Scale 13 TV-L FU ID: WiMi_MatCo65_08-2022

PositionNeuroscience

Jörn Diedrichsen

Diedrichsen Lab, Western University
Western University, Canada
Dec 5, 2025

We are looking to recruit a new postdoctoral associate for a large collaborative project on the anatomical development of the human cerebellum. The overall goal of the project is to develop a high-resolution normative model of human cerebellar development across the entire life span. The successful candidate will join the Diedrichsen Lab (Western University, Canada) and will work with a team of colleagues at Erasmus Medical Center, the Donders Institute (Netherlands), McGill, Dalhousie, Sick Kids, and UBC (Canada).

SeminarNeuroscience

Biomolecular condensates as drivers of neuroinflammation

Steven Boeynaems
Department of Molecular and Human Genetics, Baylor College of Medicine Duncan Neurological Research Institute, Texas Children's Hospital, USA
Nov 3, 2025
SeminarNeuroscienceRecording

Multisensory computations underlying flavor perception and food choice

Joost Maier
Wake Forest School of Medicine
Apr 16, 2025
SeminarNeuroscience

Spatio-temporal Regulation of Gene Expression in Neurons: Insights from Imaging mRNAs Live in Action

Sulagna Das
Assistant Professor, Emory University School of Medicine
Mar 2, 2025
SeminarNeuroscience

The Promise of MitoQuinone Therapeutics in Experimental TBI

Firas H. Kobeissy
Morehouse School of Medicine (CNMB)
Feb 17, 2025
SeminarNeuroscience

Circuit Mechanisms of Remote Memory

Lauren DeNardo, PhD
Department of Physiology, David Geffen School of Medicine, UCLA
Feb 10, 2025

Memories of emotionally-salient events are long-lasting, guiding behavior from minutes to years after learning. The prelimbic cortex (PL) is required for fear memory retrieval across time and is densely interconnected with many subcortical and cortical areas involved in recent and remote memory recall, including the temporal association area (TeA). While the behavioral expression of a memory may remain constant over time, the neural activity mediating memory-guided behavior is dynamic. In PL, different neurons underlie recent and remote memory retrieval and remote memory-encoding neurons have preferential functional connectivity with cortical association areas, including TeA. TeA plays a preferential role in remote compared to recent memory retrieval, yet how TeA circuits drive remote memory retrieval remains poorly understood. Here we used a combination of activity-dependent neuronal tagging, viral circuit mapping and miniscope imaging to investigate the role of the PL-TeA circuit in fear memory retrieval across time in mice. We show that PL memory ensembles recruit PL-TeA neurons across time, and that PL-TeA neurons have enhanced encoding of salient cues and behaviors at remote timepoints. This recruitment depends upon ongoing synaptic activity in the learning-activated PL ensemble. Our results reveal a novel circuit encoding remote memory and provide insight into the principles of memory circuit reorganization across time.

SeminarNeuroscience

Defining Molecular Mechanisms Underlying Neurodegenerative Diseases

Celeste Karch, PhD
Washington University School of Medicine
Feb 3, 2025
SeminarNeuroscience

The Neurobiology of the Addicted Brain

Thanos Panayotis K.
Department of Pharmacology & Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo,
Jan 8, 2025
SeminarNeuroscience

An intranasal non-opioid treatment for opioid use disorder

Pothos Emmanuel
Tufts University School of Medicine, Boston, MA, USA
Dec 18, 2024
SeminarArtificial IntelligenceRecording

Why age-related macular degeneration is a mathematically tractable disease

Christine Curcio
The University of Alabama at Birmingham Heersink School of Medicine
Aug 18, 2024

Among all prevalent diseases with a central neurodegeneration, AMD can be considered the most promising in terms of prevention and early intervention, due to several factors surrounding the neural geometry of the foveal singularity. • Steep gradients of cell density, deployed in a radially symmetric fashion, can be modeled with a difference of Gaussian curves. • These steep gradients give rise to huge, spatially aligned biologic effects, summarized as the Center of Cone Resilience, Surround of Rod Vulnerability. • Widely used clinical imaging technology provides cellular and subcellular level information. • Data are now available at all timelines: clinical, lifespan, evolutionary • Snapshots are available from tissues (histology, analytic chemistry, gene expression) • A viable biogenesis model exists for drusen, the largest population-level intraocular risk factor for progression. • The biogenesis model shares molecular commonality with atherosclerotic cardiovascular disease, for which there has been decades of public health success. • Animal and cell model systems are emerging to test these ideas.

SeminarNeuroscience

Personalized medicine and predictive health and wellness: Adding the chemical component

Anne Andrews
University of California
Jul 8, 2024

Wearable sensors that detect and quantify biomarkers in retrievable biofluids (e.g., interstitial fluid, sweat, tears) provide information on human dynamic physiological and psychological states. This information can transform health and wellness by providing actionable feedback. Due to outdated and insufficiently sensitive technologies, current on-body sensing systems have capabilities limited to pH, and a few high-concentration electrolytes, metabolites, and nutrients. As such, wearable sensing systems cannot detect key low-concentration biomarkers indicative of stress, inflammation, metabolic, and reproductive status.  We are revolutionizing sensing. Our electronic biosensors detect virtually any signaling molecule or metabolite at ultra-low levels. We have monitored serotonin, dopamine, cortisol, phenylalanine, estradiol, progesterone, and glucose in blood, sweat, interstitial fluid, and tears. The sensors are based on modern nanoscale semiconductor transistors that are straightforwardly scalable for manufacturing. We are developing sensors for >40 biomarkers for personalized continuous monitoring (e.g., smartwatch, wearable patch) that will provide feedback for treating chronic health conditions (e.g., perimenopause, stress disorders, phenylketonuria). Moreover, our sensors will enable female fertility monitoring and the adoption of more healthy lifestyles to prevent disease and improve physical and cognitive performance.

SeminarNeuroscience

Development of a small molecule to promote neuroprotection and repair in progressive multiple sclerosis

Petratos Steven
Department of Neuroscience / School of Translational Medicine Monash University, Australia
Jul 7, 2024
SeminarNeuroscience

Mapping the Brain‘s Visual Representations Using Deep Learning

Katrin Franke
Byers Eye Institute, Department of Ophthalmology, Stanford Medicine
Jun 5, 2024
SeminarNeuroscience

Cerebellum-Basal Ganglia Interactions

Clément Léna& Kamran Khodakhah
Institute of Biology of the École Narmale Supérieure Resp. Albert Einstein College of Medicine
May 30, 2024
SeminarNeuroscienceRecording

The Roles of Distinct Functions of SynGAP1 in SYNGAP1-Related Disorders

Richard Huganir
Johns Hopkins Medicine
May 14, 2024
SeminarNeuroscience

Investigating dynamiCa++l mechanisms underlying cortical development and disease

Georgia Panagiotakos
Icahn School of Medicine at Mount Sinai
May 7, 2024
SeminarNeuroscienceRecording

Characterizing the causal role of large-scale network interactions in supporting complex cognition

Michal Ramot
Weizmann Inst. of Science
May 6, 2024

Neuroimaging has greatly extended our capacity to study the workings of the human brain. Despite the wealth of knowledge this tool has generated however, there are still critical gaps in our understanding. While tremendous progress has been made in mapping areas of the brain that are specialized for particular stimuli, or cognitive processes, we still know very little about how large-scale interactions between different cortical networks facilitate the integration of information and the execution of complex tasks. Yet even the simplest behavioral tasks are complex, requiring integration over multiple cognitive domains. Our knowledge falls short not only in understanding how this integration takes place, but also in what drives the profound variation in behavior that can be observed on almost every task, even within the typically developing (TD) population. The search for the neural underpinnings of individual differences is important not only philosophically, but also in the service of precision medicine. We approach these questions using a three-pronged approach. First, we create a battery of behavioral tasks from which we can calculate objective measures for different aspects of the behaviors of interest, with sufficient variance across the TD population. Second, using these individual differences in behavior, we identify the neural variance which explains the behavioral variance at the network level. Finally, using covert neurofeedback, we perturb the networks hypothesized to correspond to each of these components, thus directly testing their casual contribution. I will discuss our overall approach, as well as a few of the new directions we are currently pursuing.

SeminarNeuroscience

Modeling human brain development and disease: the role of primary cilia

Kyrousi Christina
Medical School, National and Kapodistrian University of Athens, Athens, Greece
Apr 23, 2024

Neurodevelopmental disorders (NDDs) impose a global burden, affecting an increasing number of individuals. While some causative genes have been identified, understanding the human-specific mechanisms involved in these disorders remains limited. Traditional gene-driven approaches for modeling brain diseases have failed to capture the diverse and convergent mechanisms at play. Centrosomes and cilia act as intermediaries between environmental and intrinsic signals, regulating cellular behavior. Mutations or dosage variations disrupting their function have been linked to brain formation deficits, highlighting their importance, yet their precise contributions remain largely unknown. Hence, we aim to investigate whether the centrosome/cilia axis is crucial for brain development and serves as a hub for human-specific mechanisms disrupted in NDDs. Towards this direction, we first demonstrated species-specific and cell-type-specific differences in the cilia-genes expression during mouse and human corticogenesis. Then, to dissect their role, we provoked their ectopic overexpression or silencing in the developing mouse cortex or in human brain organoids. Our findings suggest that cilia genes manipulation alters both the numbers and the position of NPCs and neurons in the developing cortex. Interestingly, primary cilium morphology is disrupted, as we find changes in their length, orientation and number that lead to disruption of the apical belt and altered delamination profiles during development. Our results give insight into the role of primary cilia in human cortical development and address fundamental questions regarding the diversity and convergence of gene function in development and disease manifestation. It has the potential to uncover novel pharmacological targets, facilitate personalized medicine, and improve the lives of individuals affected by NDDs through targeted cilia-based therapies.

SeminarNeuroscienceRecording

Currents of Hope: how noninvasive brain stimulation is reshaping modern psychiatric care; Adapting to diversity: Integrating variability in brain structure and function into personalized / closed-loop non-invasive brain stimulation for substance use disorders

Colleen Hanlon, PhD & Ghazaleh Soleimani, PhD
Brainsway / University of Minnesota
Mar 27, 2024

In March we will focus on TMS and host Ghazaleh Soleimani and Colleen Hanlon. The talks will talk place on Thursday, March 28th at noon ET – please be aware that this means 5PM CET since Boston already switched to summer time! Ghazaleh Soleimani, PhD, is a postdoctoral fellow in Dr Hamed Ekhtiari’s lab at the University of Minnesota. She is also the executive director of the International Network of tES/TMS for Addiction Medicine (INTAM). She will discuss “Adapting to diversity: Integrating variability in brain structure and function into personalized / closed-loop non-invasive brain stimulation for substance use disorders”. Colleen Hanlon, PhD, currently serves as a Vice President of Medical Affairs for BrainsWay, a company specializing in medical devices for mental health, including TMS. Colleen previously worked at the Medical University of South Carolina and Wake Forest School of Medicine. She received the International Brain Stimulation Early Career Award in 2023. She will discuss “Currents of Hope: how noninvasive brain stimulation is reshaping modern psychiatric care”. As always, we will also get a glimpse at the “Person behind the science”. Please register va talks.stimulatingbrains.org to receive the (free) Zoom link, subscribe to our newsletter, or follow us on Twitter/X for further updates!

SeminarNeuroscience

Activity-Dependent Gene Regulation in Health and Disease

Elizabeth Pollina, Eric Nestler, Michelle Monje
Washington University, Icahn School of Medicine Mount Sinai, Stanford University
Mar 26, 2024

In the last of this year’s Brain Prize webinars, Elizabeth Pollina (Washington University, USA), Eric Nestler (Icahn School of Medicine Mount Sinai, USA) and Michelle Monje (Stanford University, USA) will present their work on activity-dependent gene regulation in health and disease. Each speaker will present for 25 minutes, and the webinar will conclude with an open discussion. The webinar will be moderated by the winners of the 2023 Brain Prize, Michael Greenberg, Erin Schuman and Christine Holt.

SeminarNeuroscienceRecording

Novel approaches to non-invasive neuromodulation for neuropsychiatric disorders; Effects of deep brain stimulation on brain function in obsessive-compulsive disorder

Damiaan Denys, MD, PhD & Andrada Neacsiu, PhD
Amsterdam UMC, Netherlands / Duke University School of Medicine, Durham, USA
Feb 28, 2024

On Thursday, February 29th, we will host Damiaan Denys and Andrada Neacsiu. The talks will be followed by a shared discussion. You can register via talks.stimulatingbrains.org to receive the (free) Zoom link!

SeminarNeuroscience

Towards Human Systems Biology of Sleep/Wake Cycles: Phosphorylation Hypothesis of Sleep

Hiroki R. Ueda
Graduate School of Medicine, University of Tokyo
Jan 14, 2024

The field of human biology faces three major technological challenges. Firstly, the causation problem is difficult to address in humans compared to model animals. Secondly, the complexity problem arises due to the lack of a comprehensive cell atlas for the human body, despite its cellular composition. Lastly, the heterogeneity problem arises from significant variations in both genetic and environmental factors among individuals. To tackle these challenges, we have developed innovative approaches. These include 1) mammalian next-generation genetics, such as Triple CRISPR for knockout (KO) mice and ES mice for knock-in (KI) mice, which enables causation studies without traditional breeding methods; 2) whole-body/brain cell profiling techniques, such as CUBIC, to unravel the complexity of cellular composition; and 3) accurate and user-friendly technologies for measuring sleep and awake states, exemplified by ACCEL, to facilitate the monitoring of fundamental brain states in real-world settings and thus address heterogeneity in human.

SeminarNeuroscience

Effects of Presenilin1 FAD mutants on brain angiogenic functions and neuroprotection in Alzheimer’s Disease

Georgakopoulos Tassos
Center for Molecular Biology and Genetics of Neurodegeneration, Icahn School of Medicine at Mount Sinai, New York, USA
Nov 14, 2023
SeminarNeuroscienceRecording

Virtual Brain Twins for Brain Medicine and Epilepsy

Viktor Jirsa
Aix Marseille Université - Inserm
Nov 7, 2023

Over the past decade we have demonstrated that the fusion of subject-specific structural information of the human brain with mathematical dynamic models allows building biologically realistic brain network models, which have a predictive value, beyond the explanatory power of each approach independently. The network nodes hold neural population models, which are derived using mean field techniques from statistical physics expressing ensemble activity via collective variables. Our hybrid approach fuses data-driven with forward-modeling-based techniques and has been successfully applied to explain healthy brain function and clinical translation including aging, stroke and epilepsy. Here we illustrate the workflow along the example of epilepsy: we reconstruct personalized connectivity matrices of human epileptic patients using Diffusion Tensor weighted Imaging (DTI). Subsets of brain regions generating seizures in patients with refractory partial epilepsy are referred to as the epileptogenic zone (EZ). During a seizure, paroxysmal activity is not restricted to the EZ, but may recruit other healthy brain regions and propagate activity through large brain networks. The identification of the EZ is crucial for the success of neurosurgery and presents one of the historically difficult questions in clinical neuroscience. The application of latest techniques in Bayesian inference and model inversion, in particular Hamiltonian Monte Carlo, allows the estimation of the EZ, including estimates of confidence and diagnostics of performance of the inference. The example of epilepsy nicely underwrites the predictive value of personalized large-scale brain network models. The workflow of end-to-end modeling is an integral part of the European neuroinformatics platform EBRAINS and enables neuroscientists worldwide to build and estimate personalized virtual brains.

SeminarNeuroscience

Use of brain imaging data to improve prescriptions of psychotropic drugs - Examples of ketamine in depression and antipsychotics in schizophrenia

Xenia Marlene HART.
Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany & Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan
Oct 12, 2023

The use of molecular imaging, particularly PET and SPECT, has significantly transformed the treatment of schizophrenia with antipsychotic drugs since the late 1980s. It has offered insights into the links between drug target engagement, clinical effects, and side effects. A therapeutic window for receptor occupancy is established for antipsychotics, yet there is a divergence of opinions regarding the importance of blood levels, with many downplaying their significance. As a result, the role of therapeutic drug monitoring (TDM) as a personalized therapy tool is often underrated. Since molecular imaging of antipsychotics has focused almost entirely on D2-like dopamine receptors and their potential to control positive symptoms, negative symptoms and cognitive deficits are hardly or not at all investigated. Alternative methods have been introduced, i.e. to investigate the correlation between approximated receptor occupancies from blood levels and cognitive measures. Within the domain of antidepressants, and specifically regarding ketamine's efficacy in depression treatment, there is limited comprehension of the association between plasma concentrations and target engagement. The measurement of AMPA receptors in the human brain has added a new level of comprehension regarding ketamine's antidepressant effects. To ensure precise prescription of psychotropic drugs, it is vital to have a nuanced understanding of how molecular and clinical effects interact. Clinician scientists are assigned with the task of integrating these indispensable pharmacological insights into practice, thereby ensuring a rational and effective approach to the treatment of mental health disorders, signaling a new era of personalized drug therapy mechanisms that promote neuronal plasticity not only under pathological conditions, but also in the healthy aging brain.

SeminarNeuroscience

How Intermittent Bioenergetic Challenges Enhance Brain and Body Health

Mark Mattson
Johns Hopkins University School of Medicine
Sep 25, 2023

Humans and other animals evolved in habitats fraught with a range of environmental challenges to their bodies and brains. Accordingly, cells and organ systems possess adaptive stress-responsive signaling pathways that enable them to not only withstand environmental challenges, but also to prepare for future challenges and function more efficiently. These phylogenetically conserved processes are the foundation of the hormesis principle in which repeated exposures to low to moderate amounts of an environmental challenge improve cellular and organismal fitness. Here I describe cellular and molecular mechanisms by which cells in the brain and body respond to intermittent fasting and exercise in ways that enhance performance and counteract aging and disease processes. Switching back and forth between adaptive stress response (during fasting and exercise) and growth and plasticity (eating, resting, sleeping) modes enhances the performance and resilience of various organ systems. While pharmacological interventions that engage a particular hormetic mechanism are being developed, it seems unlikely that any will prove superior to fasting and exercise.

SeminarNeuroscience

From the guts to the brain through adaptive immunity in the prevention of Alzheimer’ disease

Pasinetti Giulio Maria
Mount Sinai Health System, Department of Neurology, New York, NY, USA / Basic and Biomedical Research and Training Program, Geriatric Research and Clinical Center (GRECC)
Sep 25, 2023

Dr. Pasinetti is the Saunders Family Chair and Professor of Neurology at Icahn School of medicine at Mount Sinai, New York. His studies allowed him to develop novel therapeutic approaches through investigation of preventable risk factors including mood disorders in the promotion of resilience against neurodegenerative disorder. In his presentation Dr. Pasinetti will discuss novel concepts about the gut-brain axis in mechanisms associated to peripheral adaptive immunity as therapeutic targets to mitigate the onset and the progression of Alzheimer’s disease and other form of dementia.

SeminarNeuroscience

From pecking order to ketamine - neural mechanism of social and emotional behavior

Hailan Hu
Zhejiang University School of Medicine, Hangzhou, China
Jun 21, 2023

Emotions and social interactions color our lives and shape our behaviors. Using animal models and engineered manipulations, we aim to understand how social and emotional behaviors are encoded in the brain, focusing on the neural circuits underlying dominance hierarchy and depression. This lecture will highlight our recent discoveries on how downward social mobility leads to depression; how ketamine tames depression by blocking burst firing in the brain’s antireward center; and, how glia-neuron interaction plays a surprising role in this process. I will also present our recent work on the mechanism underlying the sustained antidepressant activity of ketamine and its brain region specificity. With these results, we hope to illuminate on a more unified theory on ketamine’s mode of action and inspire new treatment strategies for depression.

SeminarNeuroscience

From pecking order to ketamine - neural mechanism of social and emotional behavior

Hailan Hu
Zhejiang University School of Medicine, Hangzhou, China
Jun 20, 2023

Emotions and social interactions color our lives and shape our behaviors. Using animal models and engineered manipulations, we aim to understand how social and emotional behaviors are encoded in the brain, focusing on the neural circuits underlying dominance hierarchy and depression. This lecture will highlight our recent discoveries on how downward social mobility leads to depression; how ketamine tames depression by blocking burst firing in the brain’s antireward center; and, how glia-neuron interaction plays a surprising role in this process. I will also present our recent work on the mechanism underlying the sustained antidepressant activity of ketamine and its brain region specificity. With these results, we hope to illuminate on a more unified theory on ketamine’s mode of action and inspire new treatment strategies for depression.

SeminarNeuroscience

Therapeutic Strategies for Autism: Targeting Three Levels of the Central Dogma of Molecular Biology with a Focus on SYNGAP1

Prof. Lilia Iakoucheva, PhD & Mr. Derek Hong, MS
UCSD School of Medicine
Jun 7, 2023
SeminarNeuroscience

May Webinar

Lucas L Sjulson & Jens Hjerling-Leffler
Albert Einstein College of Medicine Resp. Karolinks Institute
May 25, 2023
SeminarNeuroscienceRecording

Manipulating single-unit theta phase-locking with PhaSER: An open-source tool for real-time phase estimation and manipulation

Zoe Christenson Wick
Icahn School of Medicine at Mount Sinai
May 17, 2023
SeminarNeuroscienceRecording

Manipulating single-unit theta phase-locking with PhaSER: An open-source tool for real-time phase estimation and manipulation

Zoe Christenson-Wick
Mount Sinai School of Medicine, NY, USA
May 8, 2023

Zoe has developed an open-source tool PhaSER, which allows her to perform real-time oscillatory phase estimation and apply optogenetic manipulations at precise phases of hippocampal theta during high-density electrophysiological recordings in head-fixed mice while they navigate a virtual environment. The precise timing of single-unit spiking relative to network-wide oscillations (i.e., phase locking) has long been thought to maintain excitatory-inhibitory homeostasis and coordinate cognitive processes, but due to intense experimental demands, the causal influence of this phenomenon has never been determined. Thus, we developed PhaSER (Phase-locked Stimulation to Endogenous Rhythms), a tool which allows the user to explore the temporal relationship between single-unit spiking and ongoing oscillatory activity.

SeminarNeuroscience

How the brain uses experience to construct its multisensory capabilities

Barry E. Stein
Wake Forest School of Medicine
Apr 19, 2023

This talk will not be recorded

SeminarNeuroscienceRecording

How does the primary tumor imprint a dormancy signature in disseminated tumor cells?

Lucia Borriello
Lewis Katz School of Medicine and Fox Chase Cancer Center
Mar 29, 2023
SeminarNeuroscience

Harnessing mRNA metabolism for the development of precision gene therapy

Jeff Coller, PhD
Johns Hopkins Medicine
Mar 15, 2023
SeminarNeuroscience

Integration of 3D human stem cell models derived from post-mortem tissue and statistical genomics to guide schizophrenia therapeutic development

Jennifer Erwin, Ph.D
Lieber Institute for Brain Development; Department of Neurology and Neuroscience; Johns Hopkins University School of Medicine
Mar 14, 2023

Schizophrenia is a neuropsychiatric disorder characterized by positive symptoms (such as hallucinations and delusions), negative symptoms (such as avolition and withdrawal) and cognitive dysfunction1. Schizophrenia is highly heritable, and genetic studies are playing a pivotal role in identifying potential biomarkers and causal disease mechanisms with the hope of informing new treatments. Genome-wide association studies (GWAS) identified nearly 270 loci with a high statistical association with schizophrenia risk; however each locus confers only a small increase in risk therefore it is difficult to translate these findings into understanding disease biology that can lead to treatments. Induced pluripotent stem cell (iPSC) models are a tractable system to translate genetic findings and interrogate mechanisms of pathogenesis. Mounting research with patient-derived iPSCs has proposed several neurodevelopmental pathways altered in SCZ, such as neural progenitor cell (NPC) proliferation, imbalanced differentiation of excitatory and inhibitory cortical neurons. However, it is unclear what exactly these iPS models recapitulate, how potential perturbations of early brain development translates into illness in adults and how iPS models that represent fetal stages can be utilized to further drug development efforts to treat adult illness. I will present the largest transcriptome analysis of post-mortem caudate nucleus in schizophrenia where we discovered that decreased presynaptic DRD2 autoregulation is the causal dopamine risk factor for schizophrenia (Benjamin et al, Nature Neuroscience 2022 https://doi.org/10.1038/s41593-022-01182-7). We developed stem cell models from a subset of the postmortem cohort to better understand the molecular underpinnings of human psychiatric disorders (Sawada et al, Stem Cell Research 2020). We established a method for the differentiation of iPS cells into ventral forebrain organoids and performed single cell RNAseq and cellular phenotyping. To our knowledge, this is the first study to evaluate iPSC models of SZ from the same individuals with postmortem tissue. Our study establishes that striatal neurons in the patients with SCZ carry abnormalities that originated during early brain development. Differentiation of inhibitory neurons is accelerated whereas excitatory neuronal development is delayed, implicating an excitation and inhibition (E-I) imbalance during early brain development in SCZ. We found a significant overlap of genes upregulated in the inhibitory neurons in SCZ organoids with upregulated genes in postmortem caudate tissues from patients with SCZ compared with control individuals, including the donors of our iPS cell cohort. Altogether, we demonstrate that ventral forebrain organoids derived from postmortem tissue of individuals with schizophrenia recapitulate perturbed striatal gene expression dynamics of the donors’ brains (Sawada et al, biorxiv 2022 https://doi.org/10.1101/2022.05.26.493589).

SeminarNeuroscience

Neuron-glial interactions in health and disease: from cognition to cancer

Michelle Monje
Stanford Medicine
Mar 13, 2023

In the central nervous system, neuronal activity is a critical regulator of development and plasticity. Activity-dependent proliferation of healthy glial progenitors, oligodendrocyte precursor cells (OPCs), and the consequent generation of new oligodendrocytes contributes to adaptive myelination. This plasticity of myelin tunes neural circuit function and contributes to healthy cognition. The robust mitogenic effect of neuronal activity on normal oligodendroglial precursor cells, a putative cellular origin for many forms of glioma, suggests that dysregulated or “hijacked” mechanisms of myelin plasticity might similarly promote malignant cell proliferation in this devastating group of brain cancers. Indeed, neuronal activity promotes progression of both high-grade and low-grade glioma subtypes in preclinical models. Crucial mechanisms mediating activity-regulated glioma growth include paracrine secretion of BDNF and the synaptic protein neuroligin-3 (NLGN3). NLGN3 induces multiple oncogenic signaling pathways in the cancer cell, and also promotes glutamatergic synapse formation between neurons and glioma cells. Glioma cells integrate into neural circuits synaptically through neuron-to-glioma synapses, and electrically through potassium-evoked currents that are amplified through gap-junctional coupling between tumor cells This synaptic and electrical integration of glioma into neural circuits is central to tumor progression in preclinical models. Thus, neuron-glial interactions not only modulate neural circuit structure and function in the healthy brain, but paracrine and synaptic neuron-glioma interactions also play important roles in the pathogenesis of glial cancers. The mechanistic parallels between normal and malignant neuron-glial interactions underscores the extent to which mechanisms of neurodevelopment and plasticity are subverted by malignant gliomas, and the importance of understanding the neuroscience of cancer.

SeminarNeuroscience

Cell-type specific alterations underpinning convergent ASD phenotypes in PACS1 neurodevelopmental disorder

Alicia Guemez-Gamboa
Northwestern University Feinberg School of Medicine
Feb 7, 2023
SeminarNeuroscienceRecording

Brain mosaicism in epileptogenic cortical malformations

Stéphanie Baulac
ICM Paris
Jan 31, 2023

Focal Cortical Dysplasia (FCD) is the most common focal cortical malformation leading to intractable childhood focal epilepsy. In recent years, we and others have shown that FCD type II is caused by mosaic mutations in genes within the PI3K-AKT-mTOR-signaling pathway. Hyperactivation of the mTOR pathway accounts for neuropathological abnormalities and seizure occurrence in FCD. We further showed from human surgical FCDII tissue that epileptiform activity correlates with the density of mutated dysmorphic neurons, supporting their pro-epileptogenic role. The level of mosaicism, as defined by variant allele frequency (VAF) is thought to correlate with the size and regional brain distribution of the lesion such that when a somatic mutation occurs early during the cortical development, the dysplastic area is smaller than if it occurs later. Novel approaches based on the detection of cell-free DNA from the CSF and from trace tissue adherent to SEEG electrodes promise future opportunities for genetic testing during the presurgical evaluation of refractory epilepsy patients or in those that are not eligible for surgery. In utero-based electroporation mouse models allow to express somatic mutation during neurodevelopment and recapitulate most neuropathological and clinical features of FCDII, establishing relevant preclinical mouse models for developing precision medicine strategies.

SeminarNeuroscience

Monitoring gait outcomes in rehabilitation with human pose estimation and wearable sensors

Ronald James Cotton
Center for Bionic Medicine, Shirley Ryan AbilityLab, Chicago
Jan 25, 2023
SeminarNeuroscience

Love, death, and oxytocin: the challenges of mouse maternal care

Robert C. Froemke
Departments of Otolaryngology, Neuroscience & Physiology, Neuroscience Institute, Pain Research Center, NYU Grossman School of Medicine, USA
Jan 25, 2023
SeminarNeuroscienceRecording

A framework for detecting noncoding rare variant associations of large-scale whole-genome sequencing studies

Zilin Li
Indiana University School of Medicine
Jan 9, 2023
SeminarNeuroscienceRecording

Microglial efferocytosis: Diving into the Alzheimer's Disease gene pool

Carmen Romero-Molina & Francesca Garretti
Icahn School of Medicine at Mount Sinai
Dec 19, 2022

Genome-wide association studies and functional genomics studies have linked specific cell types, genes, and pathways to Alzheimer’s disease (AD) risk. In particular, AD risk alleles primarily affect the abundance or structure, and thus the activity, of genes expressed in macrophages, strongly implicating microglia (the brain-resident macrophages) in the etiology of AD. These genes converge on pathways (endocytosis/phagocytosis, cholesterol metabolism, and immune response) with critical roles in core macrophage functions such as efferocytosis. Here, we review these pathways, highlighting relevant genes identified in the latest AD genetics and genomics studies, and describe how they may contribute to AD pathogenesis. Investigating the functional impact of AD-associated variants and genes in microglia is essential for elucidating disease risk mechanisms and developing effective therapeutic approaches." https://doi.org/10.1016/j.neuron.2022.10.015

SeminarNeuroscience

SWEBAGS conference 2022

Nicolas Trisch
New York University School of Medicine
Nov 29, 2022
SeminarNeuroscience

NEW TREATMENTS FOR PAIN: Unmet needs and how to meet them

Multiple speakers
Nov 8, 2022

“Of pain you could wish only one thing: that it should stop. Nothing in the world was so bad as physical pain. In the face of pain there are no heroes.- George Orwell, ‘1984’ " "Neuroscience has revealed the secrets of the brain and nervous system to an extent that was beyond the realm of imagination just 10-20 years ago, let alone in 1949 when Orwell wrote his prophetic novel. Understanding pain, however, presents a unique challenge to academia, industry and medicine, being both a measurable physiological process as well as deeply personal and subjective. Given the millions of people who suffer from pain every day, wishing only, “that it should stop”, the need to find more effective treatments cannot be understated." "‘New treatments for pain’ will bring together approximately 120 people from the commercial, academic, and not-for-profit sectors to share current knowledge, identify future directions, and enable collaboration, providing delegates with meaningful and practical ways to accelerate their own work into developing treatments for pain.

SeminarNeuroscience

Neural Coding for Flexible Behavior in Prefrontal Cortex

Erin Rich
Icahn School of Medicine at Mount Sinai and the Friedman Brain Institute, New York
Nov 2, 2022
SeminarNeuroscienceRecording

Using multisensory plasticity to rehabilitate vision

Benjamin A. Rowland
Wake Forest School of Medicine
Nov 2, 2022
SeminarNeuroscienceRecording

Targeting alternative splicing of SYNGAP1 using antisense oligonucleotides

Benjamin Prosser
University of Pennsylvania Perelman School of Medicine, PhD
Sep 28, 2022
SeminarNeuroscience

Functional and translational implications of A-to-I editing in brain development and neurodevelopmental disorders

Michael Breen
Icahn School of Medicine at Mount Sinai
Sep 20, 2022
SeminarNeuroscience

Chromatin domain alterations linked to 3D genome organization in a large cohort of schizophrenia and bipolar disorder brains

Kiran Girdhar, PhD
Icahn School of Medicine at Mt. Sinai, NYC
Sep 13, 2022
SeminarNeuroscience

‘New single-cell genomic technologies to track and perturb cell identity’

Samantha Morris
Washington University School of Medicine in St. Louis
Aug 31, 2022
SeminarNeuroscience

Role of ASD risk genes on maturation of frontal-sensory cognitive control circuit

Hiro Morishita
Icahn School of Medicine at Mount Sinai
Jul 26, 2022
SeminarNeuroscience

CANCELLED

Alicia Guemez-Gamboa
Northwestern University Feinberg School of Medicine
Jul 12, 2022
SeminarNeuroscience

The glymphatic system in motor neurone disease

David Wright
Monash University
Jul 5, 2022

Neurodegenerative diseases are chronic and inexorable conditions characterised by the presence of insoluble aggregates of abnormally ubiquinated and phosphorylated proteins. Recent evidence also suggests that protein misfolding can propagate throughout the body in a prion-like fashion via the interstitial or cerebrospinal fluids (CSF). As protein aggregation occurs well before the onset of brain damage and symptoms, new biomarkers sensitive to early pathology, together with therapeutic strategies that include eliminating seed proteins and blocking cell-to-cell spread, are of vital importance. The glymphatic system, which facilitates the continuous exchange of CSF and interstitial fluid to clear the brain of waste, presents as a potential biomarker of disease severity, therapeutic target, and drug delivery system. In this webinar, Associate Professor David Wright from the Department of Neuroscience, Monash University, will outline recent advances in using MRI to investigate the glymphatic system. He will also present some of his lab’s recent work investigating glymphatic clearance in preclinical models of motor neurone disease. Associate Professor David Wright is an NHMRC Emerging Leadership Fellow and the Director of Preclinical Imaging in the Department of Neuroscience, Monash University and the Alfred Research Alliance, Alfred Health. His research encompasses the development, application and analysis of advanced magnetic resonance imaging techniques for the study of disease, with a particular emphasis on neurodegenerative disorders. Although less than three years post PhD, he has published over 60 peer-reviewed journal articles in leading neuroscience journals such as Nature Medicine, Brain, and Cerebral Cortex.

ePoster

Effects of chronic treatment with extracted active ingredients from Chinese traditional medicine formula: Yueju on alleviating depression in animal models

Sonata Suk-yu Yau, Kai Le, Ping Wang, Jiaqi Li, Can Huang, Jiasui Yu, Gang Chen

FENS Forum 2024

ePoster

Hippocampal cerebral organoids as novel tool for regenerative medicine

Marzia Di chio, Francesca Ciarpella, Benedetta Lucidi, Sissi Dolci, Ilaria Decimo

FENS Forum 2024

ePoster

Targeting M-current: A new precision medicine approach in Dravet syndrome

Stefano Iavarone, Nikolas Layer, Carmine Ostacolo, Francesco Miceli, Maurizio Taglialatela, Holger Lerche, Thomas Wuttke, Ulrike B.S. Hedrich

FENS Forum 2024